# Impilo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/impilo-2

- Industry: Healthcare IT
- Headquarters: Philadelphia, US
- Website: www.impilo.health/
- Total disclosed funding: $12M
- Latest round: Series A (Nov 14, 2024)
- Investors on record: 4

## About

Founded in 2020 and based in Pennsylvania, US, Impilo, Inc. is a digital health platform that provides 4PL logistics, patient support, and data connectivity to help healthcare providers deliver care remotely. In November 2024, Impilo, Inc. raised USD 11.5 million in series A funding led by Construct Capital, including GC1 Ventures, One Way Ventures, and 2048 Ventures. As of 2024, the company is led by its CEO, Josh Stein.

The company’s services include patient qualification, enrollment, and onboarding into remote care programs using a proprietary data engine. Impilo manages the procurement and delivery of medical devices and supplies, offering customizable and white-labeled device kits shipped directly to patients. The firm streamlines healthcare delivery through end-to-end services, integrating patient support, data management, and logistics to enhance remote care programs. Impilo’s platform provides data insights, including population health trends, billing opportunities, and patient engagement analytics. The dashboard integrates with existing EHR systems, offering real-time updates and visualizations to improve decision-making.

The organization plans to use the November 2024 funding to enhance its technology infrastructure, scale operations in new regions, refine its user experience, and launch new at-home offerings.

## Funding rounds

- Series A, Nov 14, 2024, $12M — One Way Ventures, 2048 Ventures, GC1 Ventures, Construct Capital

## Investors

- One Way Ventures (https://capitalatlas.ai/funds/one-way-ventures) — Series A
- 2048 Ventures (https://capitalatlas.ai/funds/2048-ventures) — Series A
- GC1 Ventures (https://capitalatlas.ai/funds/gc1-ventures) — Series A
- Construct Capital (https://capitalatlas.ai/funds/construct-capital) — Series A